Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study

BACKGROUND: Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19. Despite the ongoing controversies, HCQ was recommended for ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Almazrou, Saja H., Almalki, Ziyad S., Alanazi, Abdullah S., Alqahtani, Abdulhadi M., Alghamd, Saleh M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527306/
https://www.ncbi.nlm.nih.gov/pubmed/33020690
http://dx.doi.org/10.1016/j.jsps.2020.09.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527306/
https://www.ncbi.nlm.nih.gov/pubmed/33020690
http://dx.doi.org/10.1016/j.jsps.2020.09.019

Ejemplares similares